As of November 2024, Emmaus Life Sciences has a market cap of $2.15M. This makes Emmaus Life Sciences the world's 35961th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $5.15M | -4.00% |
2023 | $5.36M | -61.54% |
2022 | $13.95M | -84.43% |
2021 | $89.57M | 35.77% |
2020 | $65.97M | -37.56% |
2019 | $105.67M | -55.15% |
2018 | $235.58M | -78.47% |
2017 | $1.09B | -62.43% |
2016 | $2.91B | 50.83% |
2015 | $1.93B | -86.61% |
2014 | $14.42B | -37.78% |
2013 | $23.17B | -25.77% |
2012 | $31.22B | -83.83% |
2011 | $193.10B | -50.00% |
2010 | $386.19B | -66.67% |
2009 | $1.16T | -33.33% |
2008 | $1.74T | 12.50% |
2007 | $1.54T | -60.00% |
2006 | $3.86T | -42.86% |
2005 | $6.76T | 16.67% |
2004 | $5.79T | -94.29% |
2003 | $101.38T | 400.00% |
2002 | $20.28T | -88.00% |
2001 | $168.96T | 25.00% |
2000 | $135.17T | - |